Hou X - Search Results

1

An investigation of symptom burden and quality of life in Chinese chemo-naïve advanced lung cancer patients by using the Instrument-Cloud QOL System.

Ma Y, Yang Y, Huang Y, Zhao H, Hou X, Tian Y, Zhao Y, Xue C, Fang W, Wu X, Hu Z, Liang W, Zhou T, Qin T, Zhang L. Ma Y, et al. Among authors: hou x. Lung Cancer. 2014 Jun;84(3):301-6. doi: 10.1016/j.lungcan.2014.01.027. Epub 2014 Feb 7. Lung Cancer. 2014. PMID: 24576536

2

[Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].

Hou X, Zhang L, Zhao C, Li S, Lu LX, Han F, Shao JY, Huang PY. Hou X, et al. Ai Zheng. 2006 Jul;25(7):785-92. Ai Zheng. 2006. PMID: 16831265 Chinese.

3

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Among authors: hou j, hou x. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

4

Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases.

Zhao YY, Xue C, Hou X, Liao H, Li S, Zhao HY, Huang Y, Chen LK, Xu F, Liu JL, Zhang L. Zhao YY, et al. Among authors: hou x. Eur J Cancer. 2011 Apr;47(6):848-53. doi: 10.1016/j.ejca.2010.12.004. Epub 2011 Jan 20. Eur J Cancer. 2011. PMID: 21256000 Clinical Trial.

5

Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer.

Zhao H, Huang Y, Xue C, Chen Y, Hou X, Guo Y, Zhao L, Hu Zh, Huang Y, Luo Y, Zhang L. Zhao H, et al. Among authors: hou x. PLoS One. 2013;8(1):e54674. doi: 10.1371/journal.pone.0054674. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382938 Free PMC article.

6

Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.

Dinglin XX, Huang Y, Liu H, Zeng YD, Hou X, Chen LK. Dinglin XX, et al. Among authors: hou x. J Neurooncol. 2013 May;112(3):461-6. doi: 10.1007/s11060-013-1079-5. Epub 2013 Feb 19. J Neurooncol. 2013. PMID: 23420398 Clinical Trial.

7

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC.

Wu X, Liang W, Hou X, Lin Z, Zhao H, Huang Y, Fang W, Zhao Y, Wu J, Yang Y, Xue C, Hu Z, Zhang J, Zhang J, Ma Y, Zhou T, Qin T, Zhang L. Wu X, et al. Among authors: hou x. Onco Targets Ther. 2013 Oct 21;6:1481-91. doi: 10.2147/OTT.S51887. eCollection 2013. Onco Targets Ther. 2013. PMID: 24204163 Free PMC article.

8

Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Liang W, Wu X, Fang W, Zhao Y, Yang Y, Hu Z, Xue C, Zhang J, Zhang J, Ma Y, Zhou T, Yan Y, Hou X, Qin T, Dinglin X, Tian Y, Huang P, Huang Y, Zhao H, Zhang L. Liang W, et al. Among authors: hou x. PLoS One. 2014 Feb 12;9(2):e85245. doi: 10.1371/journal.pone.0085245. eCollection 2014. PLoS One. 2014. PMID: 24533047 Free PMC article.

9

A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.

Zhou T, Hong S, Hu Z, Hou X, Huang Y, Zhao H, Liang W, Zhao Y, Fang W, Wu X, Qin T, Zhang L. Zhou T, et al. Among authors: hou x. Tumour Biol. 2015 Jan;36(1):337-43. doi: 10.1007/s13277-014-2623-4. Epub 2014 Sep 26. Tumour Biol. 2015. PMID: 25256672

10

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials.

Hong S, Fang W, Liang W, Yan Y, Zhou T, Qin T, Wu X, Ma Y, Zhao Y, Yang Y, Hu Z, Xue C, Hou X, Chen Y, Huang Y, Zhao H, Zhang L. Hong S, et al. Among authors: hou x. Onco Targets Ther. 2014 Oct 7;7:1851-67. doi: 10.2147/OTT.S68386. eCollection 2014. Onco Targets Ther. 2014. Retraction in: Onco Targets Ther. 2016 Oct 20;9:6377. doi: 10.2147/OTT.S124095. PMID: 25336977 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,798 results

Search Page

Filters